SELECT LANGUAGE BELOW

European markets close slightly higher; Temenos up 8.8% – CNBC

8 minutes ago

European stocks end higher

European stocks rose slightly on Monday, with the Stoxx 600 index up 0.17% after gaining 1.4% last week.

Britain’s FTSE 100 index rose 0.22%, while France’s CAC40 index was flat and Germany’s DAX index fell 0.15%.

See chart…

STOXX 600 index.

2 hours ago

AstraZeneca executive says lung cancer results show strategy is working

Greg Rossi, senior vice president of European and Canadian oncology at British-Swedish drugmaker AstraZeneca, told CNBC that the three lung cancer developments the company has announced in recent days bode well for the company’s current strategy. he said.

“This shows that our strategy, centered around our portfolio, the idea of ​​addressing treatments early when there is a chance of cure, is really paying off, really benefiting patients. It shows that we have the opportunities to bring,” Rossi said.

He added: “The portfolio approach of providing medicines to all lung cancer patients, regardless of stage, is now beginning to bear fruit.”

Trial of AstraZeneca’s main anti-cancer drug Tagrisso Showed “overwhelming efficacy” The company announced Monday that it is a type of lung cancer treatment. Meanwhile, the U.S. Food and Drug Administration Approved for use with Tagrisso For some types of lung cancer, accepted another drugDato DXd, for a review of lung cancer treatment.

AstraZeneca shares rose 3% in afternoon trading.

— Jenny Reid

7 hours ago

Temenos stock rebounds 6.5% after backlash over Hindenburg report

Shares in Swiss software company Temenos rose more than 6.5% in early trading on Monday, rebounding from a sharp decline last weekend.

The stock fell 6% on Friday, adding to the previous day’s 28% decline. statement The board said it “fundamentally refutes” the report by short-seller Hindenburg Research.

of report It alleges “characteristics of earnings manipulation and serious accounting fraud” at Temenos, and made the allegations based on a four-month investigation that included interviews with 25 former employees of the company.

Tenemos shares were up 6.7% by 9:40 a.m. London time.

— Karen Gilchrist

8 hours ago

Stock gains: AstraZeneca up 3.4%, Vector down 3%

AstraZeneca shares rose 3.4% in early trading Monday after the U.S. Food and Drug Administration approved the company’s blockbuster cancer drug Tagrisso to be used in combination with chemotherapy to treat a type of lung cancer.

Meanwhile, shares in German IT company Vector fell 3% after receiving an “underweight” rating from Barclays citing the company’s limited profit outlook this year.

— Karen Gilchrist

16 hours ago

CNBC Pro: ‘Good year’ for stocks: Morgan Stanley’s Slimmon names three stocks to buy right now

The stock market has been very strong so far, with the S&P 500 index closing above 5,000 for the first time last week.

“I think this is very encouraging, because it means that earnings expectations for this year are not going to go down, they could possibly go up, and that’s important to the market,” said Andrew, Managing Director and Senior Portfolio Manager.・Mr. Slimmon said. Morgan Stanley Investment Management told CNBC.

This year will be a “good year for stocks,” Slimmon said, naming three of his favorite stocks.

CNBC Pro subscribers can read more here.

— Amara Balakrishna

16 hours ago

CNBC Pro: These are the only two ETFs that have made money every year for the past 10 years

According to research by CNBC Pro, only two exchange-traded funds around the world that invest in defensive stocks have posted positive returns every year over the past 10 years.

These two funds stood out among 8,300 equity ETFs from around the world reviewed by CNBC Pro. Both funds have more than doubled investors’ cash over the past decade.

CNBC Pro subscribers can read more here.

— Ganesh Rao

12 hours ago

European Market: Click here for opening call

European markets are set to open in negative territory on Monday.

The UK’s FTSE 100 index is expected to open 19 points lower at 7,692, Germany’s DAX is down 44 points to 17,069, France’s CAC is down 23 points to 7,745 and Italy’s FTSE MIB is expected to open 19 points lower at 7,692, according to IG data. It is expected to open at 31,716, down 91 points.

January new car registration data for Italy, Germany, France, the Netherlands and the UK is due to be released on Monday.

— Holly Ellyatt

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News